ConductScience.org, home

Paper6996481

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Shulman HM and 9 others. Am J Med, 1980. Cited by 2,398 papers, by iCite.

Cite this record

ConductScience Library. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Papers, record 6996481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6996481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.
PubMed
Journal
Am J Med
PubMed
Year
1980
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
2,398
iCite
Relative citation ratio, by iCite
73
iCite
Revised in PubMed
2022-04-08
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shulman HMH M
2Sullivan KMK M
3Weiden PLP L
4McDonald GBG B
5Striker GEG E
6Sale GEG E
7Hackman RR
8Tsoi MSM S
9Storb RR
10Thomas EDE D

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone Marrow TransplantationMajor topic
Graft vs Host DiseaseMajor topic
Adolescent
Adult
Autoantibodies
Child
Child, Preschool
Chronic Disease
Digestive System Diseases
Female
Graft vs Host Reaction
Histocompatibility
Humans
Infant
Liver Function Tests
Lung Diseases
Male
Prognosis
Skin Diseases
Transplantation, Homologous

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00412360Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by926

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,398 citations.

PMIDTitleJournalYearIn PapersSource
42839030GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party.Bone Marrow Transplant2026https://conductscience.org/library/papers/42839030PubMed
42821361Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study.Stem Cells Transl Med2026https://conductscience.org/library/papers/42821361PubMed
42730201The Impact of Induction With Azacitidine and Venetoclax Versus Intensive Chemotherapy on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia.J Hematol2026https://conductscience.org/library/papers/42730201PubMed
42686993
Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT.
Bone Marrow Transplant2026https://conductscience.org/library/papers/42686993PubMed
42575207Phenotype-Specific Associations between Graft‑Versus‑Host Disease and Post‑Transplant Outcomes.Transplant Cell Ther2026https://conductscience.org/library/papers/42575207PubMed
42443469
Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant2026https://conductscience.org/library/papers/42443469PubMed
42373850
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT.
Bone Marrow Transplant2026https://conductscience.org/library/papers/42373850PubMed
42170327Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous disease.J Hum Immun2026https://conductscience.org/library/papers/42170327PubMed
42050760GATA2 Mutations Predict Poor Prognosis in Transplanted Myeloid Neoplasms.Cancer Med2026https://conductscience.org/library/papers/42050760PubMed
41983154Post-Transplant Cyclophosphamide Allows Allogeneic Hematopoietic Stem-Cell Transplantation Across Donor Types for Nonmalignant Hematologic Diseases.J Hematol2026https://conductscience.org/library/papers/41983154PubMed
41912754Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemia.Int J Hematol2026https://conductscience.org/library/papers/41912754PubMed
41876847Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group.Bone Marrow Transplant2026https://conductscience.org/library/papers/41876847PubMed
41835915Chronic graft versus host disease in upper limb: Calling upper limb rehabilitation specialists for improving outcomes in patients.Clin Hematol Int2026https://conductscience.org/library/papers/41835915PubMed
41807605Tuberculosis after allogeneic hematopoietic stem cell transplantation: a decade nationwide case-control retrospective study in low-incidence country.Bone Marrow Transplant2026https://conductscience.org/library/papers/41807605PubMed
41795054Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement.Bone Marrow Transplant2026https://conductscience.org/library/papers/41795054PubMed
41351865
Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT.
Am J Hematol2026https://conductscience.org/library/papers/41351865PubMed
41109900Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT.Bone Marrow Transplant2026https://conductscience.org/library/papers/41109900PubMed
41102401
Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry.
Bone Marrow Transplant2026https://conductscience.org/library/papers/41102401PubMed
40830236Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party.Bone Marrow Transplant2025https://conductscience.org/library/papers/40830236PubMed
40810334
Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation.
Br J Haematol2025https://conductscience.org/library/papers/40810334PubMed

See all 926 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6996481

GET https://conductscience.org/api/papers/v1/6996481/cited_by?page=2